Pavanelli Wander R, Kaminami Mari S, Geres Juliana R, Sano Ayako, Ono Mario A, Camargo I C C, Itano Eiko N
Fundação Araucária, Curitiba, PR, Brazil.
Mycopathologia. 2007 Mar;163(3):117-28. doi: 10.1007/s11046-007-0095-4. Epub 2007 Mar 14.
Paracoccidioidomycosis (PCM) is a granulomatous disease caused by a dimorphic fungus, Paracoccidioides brasiliensis. The present study investigated the protective activity of the P. brasiliensis high-molecular-mass (hMM) fraction (approximately 380 kDa) in experimental murine PCM. In the first step, lymphocyte proliferation and production of IFNgamma (but not IL-4) were observed in "in vitro" spleen cells (from female BALB/c mice infected (i.v.) with P. brasiliensis) that were stimulated with hMM fractions. In the second step, female BALB/c mice were previously immunized (s.c.) with hMM fraction (25 microg/protein = F-25 and 50 microg/protein = F-50), and the colony-forming units (CFU) of the lung and spleen, the histopathological characteristics of the granulomatous lesions, and plasmatic gp43 soluble antigens and anti-hMM IgG levels were analyzed at 28 and 56 days after infection. The lung and liver CFU were lower in mice previously immunized with the hMM fraction (P < 0.05). The granulomatous lesions revealed a greater degree of compaction and organization, with no dissemination of the fungus to other organs. Lower soluble antigen levels (P < 0.05) and higher IgG anti-hMM fraction (P < 0.05) were observed in immunized groups. The results for CFU, histopathology and antigenemia suggest that the hMM fraction has a protective effect in experimental paracoccidioidomycosis in BALB/c mice.
副球孢子菌病(PCM)是一种由双相真菌巴西副球孢子菌引起的肉芽肿性疾病。本研究调查了巴西副球孢子菌高分子量(hMM)组分(约380 kDa)在实验性小鼠PCM中的保护活性。第一步,在用hMM组分刺激的“体外”脾细胞(来自经静脉注射巴西副球孢子菌感染的雌性BALB/c小鼠)中观察到淋巴细胞增殖和IFNγ(而非IL-4)的产生。第二步,雌性BALB/c小鼠预先皮下注射hMM组分(25μg/蛋白 = F-25和50μg/蛋白 = F-50),并在感染后28天和56天分析肺和脾的菌落形成单位(CFU)、肉芽肿病变的组织病理学特征、血浆gp43可溶性抗原和抗hMM IgG水平。预先用hMM组分免疫的小鼠肺和肝CFU较低(P < 0.05)。肉芽肿病变显示出更高程度的致密性和组织化,真菌未扩散至其他器官。在免疫组中观察到较低的可溶性抗原水平(P < 0.05)和较高的抗hMM组分IgG(P < 0.05)。CFU、组织病理学和抗原血症的结果表明,hMM组分在BALB/c小鼠实验性副球孢子菌病中具有保护作用。